<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Nephrourol Mon</journal-id><journal-id journal-id-type="iso-abbrev">Nephrourol Mon</journal-id><journal-id journal-id-type="doi">10.5812/numonthly</journal-id><journal-id journal-id-type="publisher-id">Kowsar</journal-id><journal-title-group><journal-title>Nephro-urology Monthly</journal-title></journal-title-group><issn pub-type="ppub">2251-7006</issn><issn pub-type="epub">2251-7014</issn><publisher><publisher-name>Kowsar</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24282796</article-id><article-id pub-id-type="pmc">3830912</article-id><article-id pub-id-type="doi">10.5812/numonthly.11870</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Does Living Donor Hyperoxia Have an Impact on Kidney Graft Function After Transplantation?</article-title><alt-title alt-title-type="short">Kidney Transplantation Preconditioning</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Rostami</surname><given-names>Zohreh</given-names></name><xref ref-type="aff" rid="aff16021">1</xref><xref ref-type="corresp" rid="cor16022">*</xref></contrib><contrib contrib-type="author"><name><surname>Einollahi</surname><given-names>Behzad</given-names></name><xref ref-type="aff" rid="aff16021">1</xref></contrib><contrib contrib-type="author"><name><surname>Ghadiani</surname><given-names>Mohammad Hassan</given-names></name><xref ref-type="aff" rid="aff16023">2</xref></contrib></contrib-group><aff id="aff16021"><label>1</label>Nephrology and Urology Research Center, Baqiyatallah University of Medical Sciences, Tehran, IR Iran</aff><aff id="aff16023"><label>2</label>Shahid Beheshti University of Medical Sciences, Tehran, IR Iran</aff><author-notes><corresp id="cor16022"><label>*</label>Corresponding author: Zohreh Rostami, Nephrology and Urology Research Center, Baqiyatallah University of Medical Sciences, Tehran, IR Iran. Tel: +98-9121544897, Fax: +98-2181262073, E-mail: <email>rostami@numonthly.com</email>.</corresp></author-notes><pub-date pub-type="epub"><day>19</day><month>6</month><year>2013</year></pub-date><pub-date pub-type="ppub"><day>01</day><month>7</month><year>2013</year></pub-date><volume>5</volume><issue>3</issue><fpage>835</fpage><lpage>839</lpage><history><date date-type="received"><day>20</day><month>4</month><year>2013</year></date><date date-type="accepted"><day>06</day><month>5</month><year>2013</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2013, Nephrology and Urology Research Center</copyright-statement><copyright-year>2013</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Background</title><p>Improvement in the outcome of organ transplantation is related to advances in patient selection criteria, organ preservation, operative techniques, perioperative care and efficacy of immunosuppressive agents.</p></sec><sec><title>Objectives</title><p>We aimed to evaluate the effects of higher levels of arterial PaO<sub>2</sub> in donors on DGF (delayed graft function).</p></sec><sec><title>Patients and Methods</title><p>Forty patients over 18 years old with stage 4-5 chronic kidney disease (CKD) who received a kidney from living donors were enrolled. They were randomly grouped in to the case (n = 17) and control (n = 23) groups and were followed for 2 weeks after transplantation. Donors were exposed to 60% oxygen for at least 2 hours with a face-mask (venture mask) for 2 consecutive days before transplantation until arterial oxygen pressure increased in arterial blood gas to 200 mmHg. Neutrophil gelatinase associated lipocalin (NGAL), Interleuk-18 (IL-18), tumor necrosis factor- &#x003b1; (TNF-&#x003b1;) and transforming growth factor&#x02013;&#x003b2; (TGF-&#x003b2;) could be good biomarkers for early diagnosis of kidney injury in renal transplant recipients; we assessed kidney function with these biomarkers.</p></sec><sec><title>Results</title><p>Forty living kidney transplantations including 17 cases and 23 controls were performed; female gender was more prevalent in recipients (n = 16, 40%). The mean age of recipients was 36.1 &#x000b1; 12.4 (18-67) years old. DGF was detected in 2 (5.95%) individuals, from whom one was in the case group and the other one in the control group. In the univariate analysis, there was no significant correlation between age and biomarkers in urine and serum unless for the second serum NGAL (P = 0.02, r = -0.06) and second urine IL 18 (P = 0.03, r = -0.5) which had a negative correlation, and first urine TNF &#x003b1; (P = 0.02, r = 0.7) which had a positive correlation.</p></sec><sec><title>Conclusions</title><p>Oxygen therapy in the case group had no significant impact on protection from DGF.</p></sec></abstract><kwd-group kwd-group-type="author"><kwd>Oxygen Inhalation Therapy</kwd><kwd>Kidney</kwd><kwd>Transplantation</kwd><kwd>Delayed Graft Function</kwd></kwd-group></article-meta></front><body><sec id="sec16325"><title>1. Background</title><p>Parallel to the rapid growth of the incidence of end stage renal disease (ESRD) (<xref ref-type="bibr" rid="A11870R1">1</xref>), demand for kidney transplants has grown faster than the actual supply of kidneys (<xref ref-type="bibr" rid="A11870R2">2</xref>). However, ESRD has been estimated to be between 15 and 80 per one million individuals (<xref ref-type="bibr" rid="A11870R3">3</xref>). Deceased donor kidney transplants offer an additional possibility for patients requiring renal replacement therapy. Nevertheless, the improvement in the outcome of organ transplantation is related to advances in patient selection criteria, organ preservation, operative techniques, perioperative care and efficacy of immunosuppressive agents (<xref ref-type="bibr" rid="A11870R4">4</xref>).</p><p>Delayed graft function (DGF) defined by the need for dialysis within the first week post-transplantation, portends a foreshortened allograft survival of 73% by the first year compared to 83% for recipients who do not require dialysis (<xref ref-type="bibr" rid="A11870R5">5</xref>). The reported incidence of DGF from various centers ranges from 13.3 to 52 % (<xref ref-type="bibr" rid="A11870R5">5</xref>). Organ preservation has an impact on allograft renal function (<xref ref-type="bibr" rid="A11870R2">2</xref>). On the other hand, hyperbaric oxygen (HBO) therapy has been revealed to modulate both cellular and humoral immune response as well as lessen the severity of reperfusion injury (<xref ref-type="bibr" rid="A11870R2">2</xref>). However, there is no evidence for the harmful effect of oxygen challenge via invasive mechanical ventilation on the risk of DGF in deceased donors before recovery of kidney.</p></sec><sec id="sec16326"><title>2. Objectives</title><p>Although, oxygen is a vital substrate in the reduction of hypoxia, anoxia and ischemia, it also acts as a toxic metabolite due to reactive oxygen species (ROS) production (<xref ref-type="bibr" rid="A11870R2">2</xref>, <xref ref-type="bibr" rid="A11870R3">3</xref>). On the other hand, elevated oxygen tension during reperfusion may actually promote necrosis (<xref ref-type="bibr" rid="A11870R6">6</xref>).</p><p>Regarding this controversy, the authors attempted to evaluate the effects of higher levels of arterial PaO<sub>2</sub> in donors on DGF. Also, this paper provides an overview of the relationship between oxygen therapy and DGF and the potential harmful impacts of oxygen therapy in kidney transplantation.</p></sec><sec id="sec16332"><title>3. Patients and Methods</title><sec id="sec16327"><title>3.1. Participants</title><p>This cross-sectional study was initiated after the protocol was approval by the Baqiyatallah Medical University Ethics Committee and informed consent was obtained regularly from all recipients and donors between 2006 and 2007.</p><p>Forty patients over 18 years of age with stage 4-5 chronic kidney disease (CKD) who received a kidney from a living donor were enrolled. They were randomly grouped in to the case (n = 17) and control (n = 23) groups and were followed for 2 weeks after transplantation.</p><p>The recipients who had long ischemic time, vascular problems, hemodynamic instability during operation, history of smoking and diabetes were excluded. In addition, donors with past medical history of pnumothrax, asthem, seizures, optic neuritis, middle ear surgery and heavy smokers were excluded.</p><p>The immunosuppressive protocol was a triple therapy initiated by cyclosporine (6 mg/kg/day), mycophenolate mofetil (1 g/day) and prednisolone (2 mg/kg/day). As neutrophil gelatinase associated lipocalin (NGAL) (<xref ref-type="bibr" rid="A11870R7">7</xref>, <xref ref-type="bibr" rid="A11870R8">8</xref>), interleuk-18 (IL-18), tumor necrosis factor-&#x003b1; (TNF-&#x003b1;), transforming growth factor-&#x003b2; (TGF-&#x003b2;) could be good biomarkers for early diagnosis of kidney injury in renal transplant recipients, we assessed kidney function with these biomarkers.</p></sec><sec id="sec16328"><title>3.2. Oxygen Protocol</title><p>Donors were exposed to 60% oxygen for at least 2 hours with a face-mask (venture mask) for 2 consecutive days before transplantation until arterial oxygen pressure increased in arterial blood gas to 200 mmHg.</p></sec><sec id="sec16329"><title>3.3. Variables</title><p>Following variables were gathered for all recipients: age, gender and urine NGAL, IL-18, TNF-&#x003b1;, TGF-&#x003b2; for consecutive days.</p></sec><sec id="sec16330"><title>3.4. Definitions</title><p>DGF was defined as dialysis requirement in the first week after kidney transplantation (<xref ref-type="bibr" rid="A11870R9">9</xref>).</p></sec><sec id="sec16331"><title>3.5. Statistical Analysis</title><p>Data were analyzed with SPSS, version 17.0. Quantitative variables have been expressed as mean &#x000b1; SD and qualitative variables have been shown by percentages. Continuous data were compared by Student&#x02019;s t-test and categorical data were analyzed using the Chi-square or Fisher&#x02019;s exact test. P values less than 0.05 were significant.</p></sec></sec><sec id="sec16335"><title>4. Results</title><sec id="sec16333"><title>4.1. General Characteristics</title><p>Forty living kidney transplantations including 17 cases and 23 controls were performed; female gender was more prevalent in recipients (n = 16, 40%). In the case group male: female ratio was 1:2.4 while in the control group, this was 1.3:1 (P = 0.1). The mean age of recipients was 36.1 &#x000b1; 12.4 (18-67) years old. DGF was detected in 2 (5.95%) individuals, of whom one was in the case group and the other one in control group. Mean of serum and urine detected biomarkers are summarized in <xref ref-type="table" rid="tbl4736">Table 1</xref>. Nonparametric correlation between age and urine or blood kidney injury biomarkers after transplantation in the case group is summarized in <xref ref-type="table" rid="tbl4737">Table 2</xref>.</p><table-wrap id="tbl4736" orientation="portrait" position="float"><label>Table 1.</label><caption><title>Mean and Standard Deviation of Serum and Urine Kidney Injury Biomarkers During 4 Days</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">
Biomarker
</th><th align="left" rowspan="1" colspan="1">
Mean &#x000b1; SD (min-max)
</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">
<bold>Urine NGAL 1<sup><xref ref-type="table-fn" rid="fn2989">a</xref></sup></bold>
</td><td rowspan="1" colspan="1">
534.55 &#x000b1; 460.8 (5-1190)
</td></tr><tr><td rowspan="1" colspan="1">
<bold>Urine NGAL 2</bold>
</td><td rowspan="1" colspan="1">
227.27 &#x000b1; 366.001 (5-1215)
</td></tr><tr><td rowspan="1" colspan="1">
<bold>Urine NGAL 3</bold>
</td><td rowspan="1" colspan="1">
100.38 &#x000b1; 187.4 (5-710)
</td></tr><tr><td rowspan="1" colspan="1">
<bold>Urine NGAL 4</bold>
</td><td rowspan="1" colspan="1">
124.17 &#x000b1; 152.52 (25-430)
</td></tr><tr><td rowspan="1" colspan="1">
<bold>Serum NGAL 1</bold>
</td><td rowspan="1" colspan="1">
788.95 &#x000b1; 535.19 (40-1900)
</td></tr><tr><td rowspan="1" colspan="1">
<bold>Serum NGAL 2</bold>
</td><td rowspan="1" colspan="1">
395.38 &#x000b1; 438.35 (910-1940)
</td></tr><tr><td rowspan="1" colspan="1">
<bold>Serum NGAL 3</bold>
</td><td rowspan="1" colspan="1">
325.2 &#x000b1; 230.9 (915-1010)
</td></tr><tr><td rowspan="1" colspan="1">
<bold>Serum NGAL 4</bold>
</td><td rowspan="1" colspan="1">
237.89 &#x000b1; 225.55 (10-980)
</td></tr><tr><td rowspan="1" colspan="1">
<bold>IL 18, 1<sup><xref ref-type="table-fn" rid="fn2989">a</xref></sup></bold>
</td><td rowspan="1" colspan="1">
10.19 &#x000b1; 1714.6 (0-5000)
</td></tr><tr><td rowspan="1" colspan="1">
<bold>IL 18, 2</bold>
</td><td rowspan="1" colspan="1">
1148.2 &#x000b1; 1711.2 (0-5000)
</td></tr><tr><td rowspan="1" colspan="1">
<bold>IL 18, 3</bold>
</td><td rowspan="1" colspan="1">
1211.38 &#x000b1; 1582.6 (115-5000)
</td></tr><tr><td rowspan="1" colspan="1">
<bold>IL 18, 4</bold>
</td><td rowspan="1" colspan="1">
1177.73 &#x000b1; 1496.6 (0-5000)
</td></tr><tr><td rowspan="1" colspan="1">
<bold>TNF &#x003b1;, 1<sup><xref ref-type="table-fn" rid="fn2989">a</xref></sup></bold>
</td><td rowspan="1" colspan="1">
31.75 &#x000b1; 37.8 (0-120)
</td></tr><tr><td rowspan="1" colspan="1">
<bold>TNF &#x003b1;, 2</bold>
</td><td rowspan="1" colspan="1">
96 &#x000b1; 177.2 (10-680)
</td></tr><tr><td rowspan="1" colspan="1">
<bold>TNF &#x003b1;, 3</bold>
</td><td rowspan="1" colspan="1">
208.9 &#x000b1; 313.74 (10-1000)
</td></tr><tr><td rowspan="1" colspan="1">
<bold>TNF &#x003b1;, 4</bold>
</td><td rowspan="1" colspan="1">
279.6 &#x000b1; 313.9 (12-1000)
</td></tr><tr><td rowspan="1" colspan="1">
<bold>TGF &#x003b2;, 1<sup><xref ref-type="table-fn" rid="fn2989">a</xref></sup></bold>
</td><td rowspan="1" colspan="1">
4760 &#x000b1; 3669.76 (0-12000)
</td></tr><tr><td rowspan="1" colspan="1">
<bold>TGF &#x003b2;, 2</bold>
</td><td rowspan="1" colspan="1">
4104.17 &#x000b1; 2703.18 (470-9000)
</td></tr><tr><td rowspan="1" colspan="1">
<bold>TGF &#x003b2;, 3</bold>
</td><td rowspan="1" colspan="1">
2705.38 &#x000b1; 2208.15 (0-8000)
</td></tr><tr><td rowspan="1" colspan="1">
<bold>TGF &#x003b2;, 4</bold>
</td><td rowspan="1" colspan="1">
3900.6 &#x000b1; 2480.15 (220-8000)
</td></tr></tbody></table><table-wrap-foot><fn id="fn2989"><p><sup>a</sup>Abbreviations: NGAL, neutrophil gelatinase associated lipocalin; IL-18, Interleuk-18; TNF-&#x003b1;, tumor necrosis factor- &#x003b1;; TGF-&#x003b2;, transforming growth factor&#x02013;&#x003b2; </p></fn></table-wrap-foot></table-wrap><table-wrap id="tbl4737" orientation="portrait" position="float"><label>Table 2.</label><caption><title>Nonparametric Correlation Between Age and Urine or Blood Kidney Injury Biomarkers After Transplantation in Case Group During 4 Days</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">
</th><th align="left" rowspan="1" colspan="1">
Correlation (r)
</th><th align="left" rowspan="1" colspan="1">
P 
</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">
<bold>Urine NGAL 1<sup><xref ref-type="table-fn" rid="fn2990">a</xref></sup></bold>
</td><td rowspan="1" colspan="1">
0.08
</td><td rowspan="1" colspan="1">
0.8
</td></tr><tr><td rowspan="1" colspan="1">
<bold>Urine NGAL 2</bold>
</td><td rowspan="1" colspan="1">
0
</td><td rowspan="1" colspan="1">
1
</td></tr><tr><td rowspan="1" colspan="1">
<bold>Urine NGAL 3</bold>
</td><td rowspan="1" colspan="1">
0.4
</td><td rowspan="1" colspan="1">
0.7
</td></tr><tr><td rowspan="1" colspan="1">
<bold>Urine NGAL 4</bold>
</td><td rowspan="1" colspan="1">
-
</td><td rowspan="1" colspan="1">
-
</td></tr><tr><td rowspan="1" colspan="1">
<bold>Serum NGAL 1</bold>
</td><td rowspan="1" colspan="1">
0.3
</td><td rowspan="1" colspan="1">
0.4
</td></tr><tr><td rowspan="1" colspan="1">
<bold>Serum NGAL 2</bold>
</td><td rowspan="1" colspan="1">
-0.6
</td><td rowspan="1" colspan="1">
0.02
</td></tr><tr><td rowspan="1" colspan="1">
<bold>Serum NGAL 3</bold>
</td><td rowspan="1" colspan="1">
-0.03
</td><td rowspan="1" colspan="1">
0.9
</td></tr><tr><td rowspan="1" colspan="1">
<bold>Serum NGAL 4</bold>
</td><td rowspan="1" colspan="1">
-0.6
</td><td rowspan="1" colspan="1">
0.05
</td></tr><tr><td rowspan="1" colspan="1">
<bold>IL 18, 1<sup><xref ref-type="table-fn" rid="fn2990">a</xref></sup></bold>
</td><td rowspan="1" colspan="1">
-0.6
</td><td rowspan="1" colspan="1">
0.07
</td></tr><tr><td rowspan="1" colspan="1">
<bold>IL 18, 2</bold>
</td><td rowspan="1" colspan="1">
-0.5
</td><td rowspan="1" colspan="1">
0.03
</td></tr><tr><td rowspan="1" colspan="1">
<bold>IL 18, 3</bold>
</td><td rowspan="1" colspan="1">
-0.2
</td><td rowspan="1" colspan="1">
0.5
</td></tr><tr><td rowspan="1" colspan="1">
<bold>IL 18, 4</bold>
</td><td rowspan="1" colspan="1">
0.1
</td><td rowspan="1" colspan="1">
0.6
</td></tr><tr><td rowspan="1" colspan="1">
<bold>TNF &#x003b1;, 1<sup><xref ref-type="table-fn" rid="fn2990">a</xref></sup></bold>
</td><td rowspan="1" colspan="1">
0.7
</td><td rowspan="1" colspan="1">
0.02
</td></tr><tr><td rowspan="1" colspan="1">
<bold>TNF &#x003b1;, 2</bold>
</td><td rowspan="1" colspan="1">
0.6
</td><td rowspan="1" colspan="1">
0.07
</td></tr><tr><td rowspan="1" colspan="1">
<bold>TNF &#x003b1;, 3</bold>
</td><td rowspan="1" colspan="1">
0.5
</td><td rowspan="1" colspan="1">
0.6
</td></tr><tr><td rowspan="1" colspan="1">
<bold>TNF &#x003b1;, 4</bold>
</td><td rowspan="1" colspan="1">
0.03
</td><td rowspan="1" colspan="1">
0.9
</td></tr><tr><td rowspan="1" colspan="1">
<bold>TGF &#x003b2;, 1<sup><xref ref-type="table-fn" rid="fn2990">a</xref></sup></bold>
</td><td rowspan="1" colspan="1">
0.07
</td><td rowspan="1" colspan="1">
0.8
</td></tr><tr><td rowspan="1" colspan="1">
<bold>TGF &#x003b2;, 2</bold>
</td><td rowspan="1" colspan="1">
-0.7
</td><td rowspan="1" colspan="1">
0.1
</td></tr><tr><td rowspan="1" colspan="1">
<bold>TGF &#x003b2;, 3</bold>
</td><td rowspan="1" colspan="1">
-0.7
</td><td rowspan="1" colspan="1">
0.1
</td></tr><tr><td rowspan="1" colspan="1">
<bold>TGF &#x003b2;, 4</bold>
</td><td rowspan="1" colspan="1">
0.2
</td><td rowspan="1" colspan="1">
0.4
</td></tr></tbody></table><table-wrap-foot><fn id="fn2990"><p><sup>a</sup>Abbreviations: NGAL, neutrophil gelatinase associated lipocalin; IL-18, Interleuk-18; TNF-&#x003b1;, tumor necrosis factor- &#x003b1;; TGF-&#x003b2;, transforming growth factor&#x02013;&#x003b2;</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec16334"><title>4.2. Univaritate Analysis</title><p>In the univariate analysis, there was no significant correlation between age and biomarkers in urine and serum unless for the second serum NGAL (P = 0.02, r = -0.06), second urine IL 18 (P = 0.03, r = -0.5) which had a negative correlation, and first urine TNF-&#x003b1; (P = 0.02, r = 0.7) which had a positive correlation. Oxygen therapy in the case group had no significant impact on protection from DGF.</p></sec></sec><sec id="sec16336"><title>5. Discussion</title><p>In the current study, we studied the effect of donor hyperoxia (PaO<sub>2</sub> &#x02265; 200 mmHg) on kidney function after kidney transplantation. Despite the mentioned beneficial effects of hyperbaric oxygen (HBO), we revealed that donor hyperoxia, was not associated with advantages. Einollahi et al. in 2011 (<xref ref-type="bibr" rid="A11870R4">4</xref>) showed that this level of hyperoxia resulted in 5 folds probability for DGF presentation compared to PaO<sub>2 </sub>less than 200 mmHg in deceased donor. According to the previous studies (<xref ref-type="bibr" rid="A11870R3">3</xref>, <xref ref-type="bibr" rid="A11870R10">10</xref>, <xref ref-type="bibr" rid="A11870R11">11</xref>), hyperbaric oxygen exposure can preserve organs in a more optimal condition for transplantation. Although experimental studies have suggested that hyperoxia induced by hyperbaric oxygen may be favorable in the management of reperfusion injury, its mechanism remains unclear (<xref ref-type="bibr" rid="A11870R10">10</xref>). However, there are also reports on the immunomodulatory effects of hyperbaric oxygen, which have been directed towards its effect on ischemia reperfusion injury (IRI) (<xref ref-type="bibr" rid="A11870R12">12</xref>, <xref ref-type="bibr" rid="A11870R13">13</xref>). Although researchers have also demonstrated a suppressive effect on both humoral and cell mediated immunity in animal studies (<xref ref-type="bibr" rid="A11870R3">3</xref>) as well as alternation in cell surface MHC class I antigen expression (<xref ref-type="bibr" rid="A11870R3">3</xref>, <xref ref-type="bibr" rid="A11870R14">14</xref>), yet HBO has been noted to increase ROS production (<xref ref-type="bibr" rid="A11870R15">15</xref>, <xref ref-type="bibr" rid="A11870R16">16</xref>).</p><p>Moreover, the deteriorative outcome of pre-operation hyperoxia on DGF may be described by the toxic impact of oxygen-free radicals released through reperfusion of the ischemic region (<xref ref-type="bibr" rid="A11870R17">17</xref>). Oxygen-free radicals participate in lipid peroxidation and lead to endothelium and cell membrane injury, ensuing in a total defect of cellular integrity. On the other hand, cell cannot be metabolized aerobically anymore which leads to a progressive energy reduction and cytosolic Ca<sup>++</sup> overload. Reperfusion of the graft in the presence of decreased cellular energy may prone further damage resulting in cell death and possible renal allograft failure (<xref ref-type="bibr" rid="A11870R10">10</xref>). In addition, it seems that reperfusion not only leads to energy deficiency within the kidney and endothelial cells as well as the products of reactive oxygen species (ROS) but also promotes release of potent inflammatory cytokines such as tumor necrosis factor-&#x003b1; (TNF-&#x003b1;) and interleukin-1 (IL-1) (<xref ref-type="bibr" rid="A11870R18">18</xref>) as well as factors such as the pro-apoptotic tumor protein p53 gene (TP53) and the anti-apoptotic, antioxidant heme oxygenase 1 gene (HMOX1) that play an important role in modulating apoptosis. Though in acute kidney injury the TNF-&#x003b1; gene, transforming growth factor &#x003b2;1 gene (TGF-&#x003b2;1), and interleukin 10 gene (IL-10) have more important effects on regulation of inflammatory response (<xref ref-type="bibr" rid="A11870R5">5</xref>). In kidney allograft, cell adhesion molecules are expressed by TNF-&#x003b1; and promote kidney damage (<xref ref-type="bibr" rid="A11870R19">19</xref>-<xref ref-type="bibr" rid="A11870R21">21</xref>). On the other hand, there is greater expression of TNF-&#x003b1; in kidney allografts with DGF than those without DGF (<xref ref-type="bibr" rid="A11870R5">5</xref>). Therefore, donor hyperoxia that enhances TNF-&#x003b1; activity could predispose recipients to DGF (<xref ref-type="bibr" rid="A11870R11">11</xref>). On the basis of previous studies, although HBO preserves tissue oxygenation but immunomodulatory effect of HBO therapy has been attributed predominantly to the hyperbaric effect rather than to hyperoxia (<xref ref-type="bibr" rid="A11870R3">3</xref>, <xref ref-type="bibr" rid="A11870R22">22</xref>). Animal studies have substantiated an inhibitory effect of HBO therapy in the absence of hyperoxia on IFN-&#x003b3;. Subsequently, despite of the increase in oxygen tension, hyperbaric oxygen affects cellular cytoskeleton, leading to a reduction in IFN-&#x003b3;. In other words mechanism of HBO immunomodulation is different from energy formation (<xref ref-type="bibr" rid="A11870R3">3</xref>).</p><p>The other mechanism of this toxic effect of HBO might be associated with lipid peroxidation which, cause cell membrane and organelle damage in the IRI state and level of injury augments during exposure to normobaric 100% oxygen (<xref ref-type="bibr" rid="A11870R3">3</xref>, <xref ref-type="bibr" rid="A11870R15">15</xref>, <xref ref-type="bibr" rid="A11870R16">16</xref>). Therefore, it seems that oxygen saturation is more important than oxygen pressure in organ damage and DGF induction.</p><p>Limitations: it is possible that the association of kidney injury with other predictors were not seen in our study. The little sample size is the most important limitation in our study.</p><p>Conclusion: The current study revealed that normobaric hyperoxia of living donors before kidney transplantation has no effect on kidney function in renal transplant recipients. Further studies are required to confirm our findings.</p></sec></body><back><ack><p>The authors would like to thank Baqiyatallah hospital kidney transplantation ward.</p></ack><fn-group><fn id="afn10729" fn-type="other"><p>
<bold>Implication for health policy/practice/research/medical education</bold> We want to evaluate a preconditioning protocol for deceased donation in kidney transplantation.</p></fn><fn id="afn10730" fn-type="other"><p>
<bold>Please cite this paper as</bold> Rostami Z, Einollahi B, Ghadiani MH. Does Living Donor Hyperoxia Have an Impact on Kidney Graft Function After Transplantation? Nephro Urol Mon.2013;5(3):835-9. DOI: 10.5812/numonthly.11870</p></fn><fn id="afn10731" fn-type="other"><p>
<bold>Authors&#x02019; Contribution</bold> Dr Einollahi: design and data analysis, Dr Rostami: writing, Dr Ghadiani: data collection.</p></fn><fn id="afn10732" fn-type="financial-disclosure"><p>
<bold>Financial Disclosure</bold> The authors declare that there are no conflicts of interest.</p></fn><fn id="afn10733" fn-type="supported-by"><p>
<bold>Funding/Support</bold> Nephrology and Urology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.</p></fn></fn-group><ref-list><title>References</title><ref id="A11870R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilbertson</surname><given-names>DT</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Xue</surname><given-names>JL</given-names></name><name><surname>Louis</surname><given-names>TA</given-names></name><name><surname>Solid</surname><given-names>CA</given-names></name><name><surname>Ebben</surname><given-names>JP</given-names></name><etal>et al.</etal></person-group><article-title>Projecting the number of patients with end-stage renal disease in the United States to the year 2015.</article-title><source>J Am Soc Nephrol.</source><year>2005</year><volume>16</volume><issue>12</issue><fpage>3736</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1681/ASN.2005010112</pub-id><pub-id pub-id-type="pmid">16267160</pub-id></element-citation></ref><ref id="A11870R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muralidharan</surname><given-names>V</given-names></name><name><surname>Christophi</surname><given-names>C</given-names></name></person-group><article-title>Hyperbaric oxygen therapy and liver transplantation.</article-title><source>HPB (Oxford).</source><year>2007</year><volume>9</volume><issue>3</issue><fpage>174</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1080/13651820601175926</pub-id><pub-id pub-id-type="pmid">18333218</pub-id></element-citation></ref><ref id="A11870R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Israni</surname><given-names>AK</given-names></name><name><surname>Li</surname><given-names>N</given-names></name><name><surname>Cizman</surname><given-names>BB</given-names></name><name><surname>Snyder</surname><given-names>J</given-names></name><name><surname>Abrams</surname><given-names>J</given-names></name><name><surname>Joffe</surname><given-names>M</given-names></name><etal>et al.</etal></person-group><article-title>Association of donor inflammation- and apoptosis-related genotypes and delayed allograft function after kidney transplantation.</article-title><source>Am J Kidney Dis.</source><year>2008</year><volume>52</volume><issue>2</issue><fpage>331</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1053/j.ajkd.2008.05.006</pub-id><pub-id pub-id-type="pmid">18640487</pub-id></element-citation></ref><ref id="A11870R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Einollahi</surname><given-names>B</given-names></name><name><surname>Poor-Reza-Gholi</surname><given-names>F</given-names></name><name><surname>Rezaeean</surname><given-names>S</given-names></name><name><surname>Jahani</surname><given-names>Y</given-names></name><name><surname>Nafar</surname><given-names>M</given-names></name><name><surname>Najafizadeh</surname><given-names>K</given-names></name><etal>et al.</etal></person-group><article-title>Deceased-donor hyperoxia deteriorates kidney graft function.</article-title><source>J Europ Soci Organ Transplant.</source><year>2011</year><volume>24</volume><issue>2</issue><fpage>e16</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1111/j.1432-2277.2010.01175.x</pub-id><pub-id pub-id-type="pmid">21062366</pub-id></element-citation></ref><ref id="A11870R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malago</surname><given-names>M</given-names></name><name><surname>Hertl</surname><given-names>M</given-names></name><name><surname>Testa</surname><given-names>G</given-names></name><name><surname>Rogiers</surname><given-names>X</given-names></name><name><surname>Broelsch</surname><given-names>CE</given-names></name></person-group><article-title>Split-liver transplantation: future use of scarce donor organs.</article-title><source>World J Surg.</source><year>2002</year><volume>26</volume><issue>2</issue><fpage>275</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1007/s00268-001-0216-z</pub-id><pub-id pub-id-type="pmid">11865359</pub-id></element-citation></ref><ref id="A11870R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sterling</surname><given-names>DL</given-names></name><name><surname>Thornton</surname><given-names>JD</given-names></name><name><surname>Swafford</surname><given-names>A</given-names></name><name><surname>Gottlieb</surname><given-names>SF</given-names></name><name><surname>Bishop</surname><given-names>SP</given-names></name><name><surname>Stanley</surname><given-names>AW</given-names></name><etal>et al.</etal></person-group><article-title>Hyperbaric oxygen limits infarct size in ischemic rabbit myocardium in vivo.</article-title><source>Circulation.</source><year>1993</year><volume>88</volume><issue>4 Pt 1</issue><fpage>1931</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">8403338</pub-id></element-citation></ref><ref id="A11870R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rostami</surname><given-names>Z</given-names></name><name><surname>Nikpoor</surname><given-names>M</given-names></name><name><surname>Einollahi</surname><given-names>B</given-names></name></person-group><article-title>Urinary Neutrophil Gelatinase Associated Lipocalin (NGAL) for Early Diagnosis of Acute Kidney Injury in Renal Transplant Recipients.</article-title><source>Nephro Urol Mon</source><year>2013</year><volume>5</volume><issue>2</issue><fpage>745</fpage><lpage>52</lpage></element-citation></ref><ref id="A11870R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rostami</surname><given-names>Z</given-names></name><name><surname>Heidari</surname><given-names>F</given-names></name></person-group><article-title>How neutrophil gelatinase-associated lipocalin can be presented in plasma and urine.</article-title><source>Iran J Kidney Dis.</source><year>2012</year><volume>6</volume><issue>5</issue><fpage>325</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">22976253</pub-id></element-citation></ref><ref id="A11870R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parikh</surname><given-names>CR</given-names></name><name><surname>Jani</surname><given-names>A</given-names></name><name><surname>Mishra</surname><given-names>J</given-names></name><name><surname>Ma</surname><given-names>Q</given-names></name><name><surname>Kelly</surname><given-names>C</given-names></name><name><surname>Barasch</surname><given-names>J</given-names></name><etal>et al.</etal></person-group><article-title>Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation.</article-title><source>Am J Transplant.</source><year>2006</year><volume>6</volume><issue>7</issue><fpage>1639</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1111/j.1600-6143.2006.01352.x</pub-id><pub-id pub-id-type="pmid">16827865</pub-id></element-citation></ref><ref id="A11870R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bayrakci</surname><given-names>B</given-names></name></person-group><article-title>Preservation of organs from brain dead donors with hyperbaric oxygen.</article-title><source>Pediatr Transplant.</source><year>2008</year><volume>12</volume><issue>5</issue><fpage>506</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">18672481</pub-id></element-citation></ref><ref id="A11870R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corradini</surname><given-names>SG</given-names></name><name><surname>Elisei</surname><given-names>W</given-names></name><name><surname>De Marco</surname><given-names>R</given-names></name><name><surname>Siciliano</surname><given-names>M</given-names></name><name><surname>Iappelli</surname><given-names>M</given-names></name><name><surname>Pugliese</surname><given-names>F</given-names></name><etal>et al.</etal></person-group><article-title>Preharvest donor hyperoxia predicts good early graft function and longer graft survival after liver transplantation.</article-title><source>Liver Transpl.</source><year>2005</year><volume>11</volume><issue>2</issue><fpage>140</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1002/lt.20339</pub-id><pub-id pub-id-type="pmid">15666381</pub-id></element-citation></ref><ref id="A11870R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hansbrough</surname><given-names>JF</given-names></name><name><surname>Eiseman</surname><given-names>B</given-names></name></person-group><article-title>Immunosuppression with hyperbaric oxygen.</article-title><source>Surg Forum.</source><year>1979</year><volume>30</volume><fpage>313</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">538623</pub-id></element-citation></ref><ref id="A11870R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hansbrough</surname><given-names>JF</given-names></name><name><surname>Piacentine</surname><given-names>JG</given-names></name><name><surname>Eiseman</surname><given-names>B</given-names></name></person-group><article-title>Immunosuppression by hyperbaric oxygen.</article-title><source>Surgery.</source><year>1980</year><volume>87</volume><issue>6</issue><fpage>662</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">7376077</pub-id></element-citation></ref><ref id="A11870R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacKenzie</surname><given-names>DA</given-names></name><name><surname>Sollinger</surname><given-names>HW</given-names></name><name><surname>Hullett</surname><given-names>DA</given-names></name></person-group><article-title>Decreased immunogenicity of human fetal pancreas allografts following hyperbaric oxygen culture.</article-title><source>Transplant Proc.</source><year>2003</year><volume>35</volume><issue>4</issue><fpage>1499</fpage><lpage>502</lpage><pub-id pub-id-type="pmid">12826204</pub-id></element-citation></ref><ref id="A11870R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozden</surname><given-names>TA</given-names></name><name><surname>Uzun</surname><given-names>H</given-names></name><name><surname>Bohloli</surname><given-names>M</given-names></name><name><surname>Toklu</surname><given-names>AS</given-names></name><name><surname>Paksoy</surname><given-names>M</given-names></name><name><surname>Simsek</surname><given-names>G</given-names></name><etal>et al.</etal></person-group><article-title>The effects of hyperbaric oxygen treatment on oxidant and antioxidants levels during liver regeneration in rats.</article-title><source>Tohoku J Exp Med.</source><year>2004</year><volume>203</volume><issue>4</issue><fpage>253</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">15297730</pub-id></element-citation></ref><ref id="A11870R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurir</surname><given-names>TT</given-names></name><name><surname>Markotic</surname><given-names>A</given-names></name><name><surname>Katalinic</surname><given-names>V</given-names></name><name><surname>Bozanic</surname><given-names>D</given-names></name><name><surname>Cikes</surname><given-names>V</given-names></name><name><surname>Zemunik</surname><given-names>T</given-names></name><etal>et al.</etal></person-group><article-title>Effect of hyperbaric oxygenation on the regeneration of the liver after partial hepatectomy in rats.</article-title><source>Braz J Med Biol Res.</source><year>2004</year><volume>37</volume><issue>8</issue><fpage>1231</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">15273825</pub-id></element-citation></ref><ref id="A11870R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novitzky</surname><given-names>D</given-names></name></person-group><article-title>Donor management: state of the art.</article-title><source>Transplant Proc.</source><year>1997</year><volume>29</volume><issue>8</issue><fpage>3773</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">9414921</pub-id></element-citation></ref><ref id="A11870R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colletti</surname><given-names>LM</given-names></name><name><surname>Kunkel</surname><given-names>SL</given-names></name><name><surname>Walz</surname><given-names>A</given-names></name><name><surname>Burdick</surname><given-names>MD</given-names></name><name><surname>Kunkel</surname><given-names>RG</given-names></name><name><surname>Wilke</surname><given-names>CA</given-names></name><etal>et al.</etal></person-group><article-title>The role of cytokine networks in the local liver injury following hepatic ischemia/reperfusion in the rat.</article-title><source>Hepatology.</source><year>1996</year><volume>23</volume><issue>3</issue><fpage>506</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1002/hep.510230315</pub-id><pub-id pub-id-type="pmid">8617430</pub-id></element-citation></ref><ref id="A11870R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toback</surname><given-names>FG</given-names></name></person-group><article-title>Regeneration after acute tubular necrosis.</article-title><source>Kidney Int.</source><year>1992</year><volume>41</volume><issue>1</issue><fpage>226</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">1593859</pub-id></element-citation></ref><ref id="A11870R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donnahoo</surname><given-names>KK</given-names></name><name><surname>Meng</surname><given-names>X</given-names></name><name><surname>Ayala</surname><given-names>A</given-names></name><name><surname>Cain</surname><given-names>MP</given-names></name><name><surname>Harken</surname><given-names>AH</given-names></name><name><surname>Meldrum</surname><given-names>DR</given-names></name></person-group><article-title>Early kidney TNF-alpha expression mediates neutrophil infiltration and injury after renal ischemia-reperfusion.</article-title><source>Am J Physiol.</source><year>1999</year><volume>277</volume><issue>3 Pt 2</issue><fpage>R922</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">10484513</pub-id></element-citation></ref><ref id="A11870R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daemen</surname><given-names>MA</given-names></name><name><surname>van de Ven</surname><given-names>MW</given-names></name><name><surname>Heineman</surname><given-names>E</given-names></name><name><surname>Buurman</surname><given-names>WA</given-names></name></person-group><article-title>Involvement of endogenous interleukin-10 and tumor necrosis factor-alpha in renal ischemia-reperfusion injury.</article-title><source>Transplantation.</source><year>1999</year><volume>67</volume><issue>6</issue><fpage>792</fpage><lpage>800</lpage><pub-id pub-id-type="pmid">10199725</pub-id></element-citation></ref><ref id="A11870R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Granowitz</surname><given-names>EV</given-names></name><name><surname>Skulsky</surname><given-names>EJ</given-names></name><name><surname>Benson</surname><given-names>RM</given-names></name><name><surname>Wright</surname><given-names>J</given-names></name><name><surname>Garb</surname><given-names>JL</given-names></name><name><surname>Cohen</surname><given-names>ER</given-names></name><etal>et al.</etal></person-group><article-title>Exposure to increased pressure or hyperbaric oxygen suppresses interferon-gamma secretion in whole blood cultures of healthy humans.</article-title><source>Undersea Hyperb Med.</source><year>2002</year><volume>29</volume><issue>3</issue><fpage>216</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">12670123</pub-id></element-citation></ref></ref-list></back></article>